Ausgabe 2/2004
Inhalt (9 Artikel)
Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation
Anne W. Harmon, Yashomati M. Patel
Regulation of the Estrogen Receptor α Minimal Promoter by Sp1, USF-1 and ERα
Linda A. deGraffenried, Torsten A. Hopp, Anthony J. Valente, Robert A. Clark, Suzanne A.W. Fuqua
A Family-based Genetic Association Study of Variants in Estrogen-metabolism Genes COMT and CYP1B1 and Breast Cancer Risk
Habibul Ahsan, Yu Chen, Alice S. Whittemore, Muhammad G. Kibriya, Irina Gurvich, Ruby T. Senie, Regina M. Santella
Hormonal Factors and Breast Tumor Proliferation: Do Factors that Affect Cancer Risk also Affect Tumor Growth?
Nina Oestreicher, Emily White, Kathleen E. Malone, Peggy L. Porter
A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer
Gary H. Lyman, Stephanie J. Green, Peter M. Ravdin, Charles E. Geyer Jr., Christy A. Russell, Stanley P. Balcerzak, G. Thomas Budd, Silvana Martino
Report
Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen
Michael D. Johnson, Hong Zuo, Kyung-Hoon Lee, Joseph P. Trebley, James Michael Rae, Ross V. Weatherman, Zeruesanay Desta, David A. Flockhart, Todd C. Skaar
Report
VEGF—DT385 Toxin Conjugate Inhibits Mammary Adenocarcinoma Development in a Transgenic Mouse Model of Spontaneous Tumorigenesis
R. Wild, Y. Yokoyama, R.P.M. Dings, S. Ramakrishnan
Abstract List
Updates on SABCS 2003 Abstracts
Instructions for Authors